ID

45466

Beskrivning

Principal Investigator: Matthew Hsieh, MD, National Institutes of Health, NHLBI and NIDDK, Bethesda, MD, USA MeSH: Neutropenia https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000507 Benign ethnic neutropenia (BEN) is a clinical condition more commonly observed in African-Americans. It is characterized by a relative reduction in neutrophil count by about 1000 cells per microliter, leading to a decrease in total leukocyte count by similar decrement. Previous reports of this condition showed that there was neither higher frequency nor increased severity of infections in affected individuals. Bone marrow examinations showed normal white cell maturation; and ex vivo culture of marrow cells showed low normal or slightly reduced number of myeloid colonies. Under physiologic stress, the increases in neutrophil and leukocyte counts of BEN individuals are slightly lower, compared to normal African-Americans or Caucasians. These clinical observations suggest that BEN results from a lower 'set point' for cell number in the marrow. Additionally, case reports of familial BEN, the persistence of BEN over many decades in the US, UK, and Africa, and the recent report of Duffy antigen and chemokine receptor (DARC) being associated with neutropenia, all suggest a strong genetic association to neutropenia/leukopenia. Our initial look into microarray analyses in a pilot trial of subjects showed that there were no significant differences in mRNA signals between BEN and normal subjects. Therefore, we are now proposing a larger study, utilizing Illumina Omni Express chips, to look for genetic associations. We have partnered with the Reasons for Geographic and Racial Differences in Stroke study (REGARDS), where nearly half of the cohort are African-Americans. This will be one of the few GWAS being performed in only African-Americans, and will provide valuable genetic information to link with neutropenia and possibly other conditions/diseases. Genotyping was performed by the Johns Hopkins University Center for Inherited Disease Research (CIDR). Quality control of the genotypic and phenotypic data was performed through a collaboration between CIDR and the Genetics Coordinating Center, Department of Biostatistics at the University of Washington, which is funded by a federal contract supported by 14 NIH Institutes (HHSN268200782096C).

Länk

dbGap study = phs000507

Nyckelord

Versioner (2)
  1. 2022-10-14 2022-10-14 - Chiara Middel
  2. 2022-12-13 2022-12-13 - Kristina Keller
Rättsinnehavare

Matthew Hsieh, MD, National Institutes of Health, NHLBI and NIDDK, Bethesda, MD, USA

Uppladdad den

13 december 2022

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

  • Senaste
  • Äldsta
  • Önskad
  • Senaste
    • Senaste
    • Äldsta
    • Önskad

Inga kommentarer

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

dbGaP phs000507 Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans

Engelsk

Eligibility Criteria

6 Formulär  
  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. Subject ID, consent group, subject source, and subject source ID of participants with or without benign neutropenia and involved in the "NHLBI and NIDDK Sponsored GWAS in Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans (Age >45 yrs Old) from the REGARDS" project.
    3. Subject ID, family ID, mother ID, father ID, and sex of participants with or without benign neutropenia and involved in the "NHLBI and NIDDK Sponsored GWAS in Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans (Age >45 yrs old) from the REGARDS" project.
    4. Sample ID, subject ID, sample source, sample source ID, and sample use variables obtained from participants with or without benign neutropenia and involved in the "NHLBI and NIDDK Sponsored GWAS in Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans (Age >45 yrs Old) from the REGARDS" project.
    5. Subject ID, age, gender, if participant consent to private research, State in the US where the participant resides, participant history of stroke, participant history of transient ischemic attack, cholesterol, triglycerides, C-reactive protein, blood cell count, and smoking of participants with or without benign neutropenia and involved in the "NHLBI and NIDDK Sponsored GWAS in Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans (Age >45 yrs Old) from the REGARDS" project.
    6. Sample ID, analyte type, body site where sample was obtained, and tumor status of sample of participants with or without benign neutropenia and involved in the "NHLBI and NIDDK Sponsored GWAS in Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans (Age >45 yrs Old) from the REGARDS" project.
Inclusion and exclusion criteria
Beskrivning

Inclusion and exclusion criteria

Among REGARDS study participants, African-Americans whose leukocyte counts are in the lowest 1-7th percentile are considered to be 'cases,' or 'leukopenic,' or 'neutropenic.' The controls are African-Americans whose leukocyte counts are in 85-95th percentile.
Beskrivning

Elig.phs000507.v2.p2.1

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1698493
UMLS CUI [1,2]
C0085756
UMLS CUI [1,3]
C0005771
UMLS CUI [1,4]
C0023516
UMLS CUI [1,5]
C0205251
UMLS CUI [1,6]
C1264641
UMLS CUI [2,1]
C0009932
UMLS CUI [2,2]
C0085756
UMLS CUI [2,3]
C0005771
UMLS CUI [2,4]
C0023516
UMLS CUI [2,5]
C0205250
UMLS CUI [2,6]
C1264641
Tillbaka till toppen

Similar models

Eligibility Criteria

6 Formulär
  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. Subject ID, consent group, subject source, and subject source ID of participants with or without benign neutropenia and involved in the "NHLBI and NIDDK Sponsored GWAS in Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans (Age >45 yrs Old) from the REGARDS" project.
    3. Subject ID, family ID, mother ID, father ID, and sex of participants with or without benign neutropenia and involved in the "NHLBI and NIDDK Sponsored GWAS in Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans (Age >45 yrs old) from the REGARDS" project.
    4. Sample ID, subject ID, sample source, sample source ID, and sample use variables obtained from participants with or without benign neutropenia and involved in the "NHLBI and NIDDK Sponsored GWAS in Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans (Age >45 yrs Old) from the REGARDS" project.
    5. Subject ID, age, gender, if participant consent to private research, State in the US where the participant resides, participant history of stroke, participant history of transient ischemic attack, cholesterol, triglycerides, C-reactive protein, blood cell count, and smoking of participants with or without benign neutropenia and involved in the "NHLBI and NIDDK Sponsored GWAS in Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans (Age >45 yrs Old) from the REGARDS" project.
    6. Sample ID, analyte type, body site where sample was obtained, and tumor status of sample of participants with or without benign neutropenia and involved in the "NHLBI and NIDDK Sponsored GWAS in Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans (Age >45 yrs Old) from the REGARDS" project.
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Inclusion and exclusion criteria
Elig.phs000507.v2.p2.1
Item
Among REGARDS study participants, African-Americans whose leukocyte counts are in the lowest 1-7th percentile are considered to be 'cases,' or 'leukopenic,' or 'neutropenic.' The controls are African-Americans whose leukocyte counts are in 85-95th percentile.
boolean
C1698493 (UMLS CUI [1,1])
C0085756 (UMLS CUI [1,2])
C0005771 (UMLS CUI [1,3])
C0023516 (UMLS CUI [1,4])
C0205251 (UMLS CUI [1,5])
C1264641 (UMLS CUI [1,6])
C0009932 (UMLS CUI [2,1])
C0085756 (UMLS CUI [2,2])
C0005771 (UMLS CUI [2,3])
C0023516 (UMLS CUI [2,4])
C0205250 (UMLS CUI [2,5])
C1264641 (UMLS CUI [2,6])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial